KFDA to mull over how to treat unacceptable bulk drugs
Published: 2005-06-17 06:57:00
Updated: 2005-06-17 06:57:00
The KFDA seems to be in anguish how to treat an unacceptable bulk drug with reference to the DMF, a bulk drug master file report system, which is still being reviewed on ongoing receit of its submission from the bulk suppliers.
The KFDA said that about 40% of the DMF was completed to review, ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
